Stock SWAV SHOCKWAVE MEDICAL, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Shockwave Medical, Inc.

Equities

SWAV

US82489T1043

Market Closed - Nasdaq
Other stock markets
 16:00:00 2024-04-26 EDT 		5-day change 1st Jan Change
330 USD +0.31% Intraday chart for Shockwave Medical, Inc. +0.30% +73.17%
04-11 Health Care Slips on Risk Bias -- Health Care Roundup DJ
04-09 CL King Downgrades ShockWave Medical to Neutral From Buy, Cuts Price Target to $335 From $368 MT

Evolution of the average Target Price on Shockwave Medical, Inc.

Price target over the last 5 years

History of analyst recommendation changes

d689.g83KTmaBheYU4-QvUmfbQljP8DbXSyzFttY832K1PcA.zI-fKxPP0ctTk5BpNAPtCQ-hwWDlI0moj5kK6gvvXPPtpf0XAs3PgXGNsQ~cd9bb8c6112ba0a995c2672d2e44c0dc

Analyst Recommendations on Shockwave Medical, Inc.

CL King Downgrades ShockWave Medical to Neutral From Buy, Cuts Price Target to $335 From $368 MT
Leerink Partners Downgrades ShockWave Medical to Market Perform From Outperform, Cuts Price Target to $335 From $361 MT
Deutsche Bank Downgrades ShockWave Medical to Hold From Buy, Raises Price Target to $335 From $270 MT
Morgan Stanley Downgrades ShockWave Medical to Equal Weight From Overweight, Raises Price Target to $335 From $285 MT
Wolfe Research Downgrades ShockWave Medical to Peer Perform From Outperform MT
Needham Downgrades ShockWave Medical to Hold From Buy MT
Piper Sandler Raises Price Target on ShockWave Medical to $360 From $290, Keeps Overweight Rating MT
CL King Initiates ShockWave Medical With Buy Rating, Price Target is $368 MT
UBS Raises Price Target on ShockWave Medical to $250 From $228, Maintains Neutral Rating MT
Piper Sandler Raises ShockWave Medical's Price Target to $290 From $275, Keeps Overweight Rating MT
Needham Adjusts Price Target on ShockWave Medical to $286 From $260, Keeps Buy Rating MT
Morgan Stanley Raises Price Target on ShockWave Medical to $285 From $223, Keeps Overweight Rating MT
Morgan Stanley Cuts ShockWave Medical's Price Target to $223 From $284, Maintains Overweight Rating MT
Deutsche Bank Cuts ShockWave Medical Price Target to $270 From $310, Maintains Buy Rating MT
Piper Sandler Adjusts ShockWave Medical Price Target to $275 From $315, Maintains Overweight Rating MT
Needham Cuts Price Target on ShockWave Medical to $260 From $265, Maintains Buy Rating MT
Morgan Stanley Cuts Price Target on ShockWave Medical to $284 From $313, Notes 'Peripheral Softness,' Keeps Overweight Rating MT
UBS Adjusts ShockWave Medical Price Target to $226 From $218, Maintains Neutral Rating MT
Needham Lowers ShockWave Medical's PT to $265 From $330 Due to Peer Multiple Contraction, Keeps Buy Rating MT
BofA Slashes Price Target on ShockWave Medical to $250 From $316, Keeps Buy Rating MT
UBS Initiates ShockWave Medical With Neutral Rating, Price Target is $218 MT
Morgan Stanley Adjusts Price Target on ShockWave Medical to $313 From $335, Keeps Overweight Rating MT
Wolfe Research Adjusts Price Target on ShockWave Medical to $270 From $300, Maintains Outperform Rating MT
Canaccord Genuity Adjusts Price Target on ShockWave Medical to $294 From $312, Maintains Buy Rating MT
Wells Fargo Lowers Price Target on ShockWave Medical to $251 From $275, Maintains Equalweight Rating MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
11
Last Close Price
330 USD
Average target price
294.3 USD
Spread / Average Target
-10.83%
High Price Target
348.4 USD
Spread / Highest target
+5.58%
Low Price Target
165 USD
Spread / Lowest Target
-50.00%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Shockwave Medical, Inc.

CL King
Leerink Partners
Deutsche Bank Securities
Morgan Stanley
Needham & Co.
Wolfe Research
Piper Sandler
UBS
BofA Securities
Canaccord Genuity
Wells Fargo Securities
Oppenheimer
SVB Securities LLC
SVB Leerink

Ratings for Shockwave Medical, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. SWAV Stock
  4. Consensus Shockwave Medical, Inc.